At 6.7% CAGR, Europe Cranial Implants Market is Projected to be Worth US$ 516.62 Million by 2031, says Business Market Insights

According to Business Market Insights research, the Europe cranial implants market was valued at US$ 307.23 million in 2023 and is expected to reach US$ 516.62 million by 2031, registering a CAGR of 6.7% from 2023 to 2031. Advancements in 3D printing with incorporation of original multilayer technology and customized implants are among the critical factors attributed to driving the Europe cranial implants market growth.

3D printing, also known as additive manufacturing, allows for the creation of highly customized, patient-specific cranial implants that offer improved fitness and functionality compared to traditional implants. The design and production of cranial implants have evolved with progress in this technology, enabling precise replication of an individual’s skull geometry, which reduces the risk of surgical complications and enhances recovery outcomes. The integration of multilayer technology in 3D printing further enhances these benefits. This technology enables the creation of implants with multiple layers; each designed with different properties tailored to specific functions. For instance, one layer might be engineered for structural strength, while another could focus on biocompatibility or flexibility. Multilayered 3D-printed implants can improve osseointegration (bone growth into the implant), reduce the risk of implant rejection, and offer superior protection for the brain. 3D printing allows for faster production times, lower manufacturing costs, and greater flexibility in adapting to complex cranial deformities. These advancements not only improve patient outcomes but also reduce the overall cost of treatment, making cranial implants more accessible to a broader patient population. As a result, advancements in 3D printing with the integration of original multilayer technology, offering improved surgical precision, reduced complications, and better long-term performance, present significant opportunities for the cranial implant market.

On the contrary, the risk of implant failure hampers the growth of Europe cranial implants market.

By type, the Europe cranial implants market is segmented into parietal, frontal, occipital, temporal, and sphenoid. The parietal held 33.9% share of Europe cranial implants market share in 2023, amassing US$ 104.28 million. It is projected to garner US$ 181.77 million by 2031 to register 7.2% CAGR during 2023–2031.

In terms of material, the Europe cranial implants market is segmented into polymethyl methacrylate, polyether ether ketone, titanium, and others. The polyether ether ketone held 44.7% share of Europe cranial implants market share in 2023, amassing US$ 137.31 million. It is projected to garner US$ 232.46 million by 2031 to register 6.8% CAGR during 2023–2031.

Based on end user, the Europe cranial implants market is segmented into hospitals, trauma centers, and others. The hospitals held 60.2% share of Europe cranial implants market share in 2023, amassing US$ 185.06 million. It is projected to garner US$ 323.44 million by 2031 to register 7.2% CAGR during 2023–2031.

Based on country, the Europe cranial implants market is categorized into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Our regional analysis states that Germany captured 27.1% share of Europe cranial implants market in 2023. It was assessed at US$ 83.21 million in 2023 and is likely to hit US$ 142.98 million by 2031, registering a CAGR of 7.0% during 2023–2031.

Key players operating in the cranial implants market are Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC, among others.

• On April-2024: Kelyniam Global and Fin-ceramica, Faenza S.p.a., makers of custom cranial implants, announced the launch of the NEOS Surgery Cranial LOOP fixation system has received 510(k) clearance from the FDA for use with Finceramica's Customized Bone hydroxyapatite cranial implant.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com